Life Sciences Updates from Cooley LLPhttp://www.cooley.comReston, Va. – January 26, 2012 – Amgen and Micromet, Inc. today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company with its research and development center in Munich and headquarters in Rockville, Md., for $11...http://www.cooley.com/showpressrelease.aspx?Show=66070Thu, 26 Jan 2012 00:00:00 GMT On December 19, 2011, the Centers for Medicare and Medicaid ("CMS") published a proposed rule implementing the "sunshine provisions" in Section 6002 of the Patient Protection and Affordable Care Act ("PPACA"). These provisions require (i) applicable manufacturers to report annually to CMS certain p...http://www.cooley.com/showalert.aspx?Show=66048Fri, 20 Jan 2012 00:00:00 GMT Among other things, 2012 will be the year of the Department of Health and Human Services ("HHS") Office of Civil Rights ("OCR") pilot audit program to assess compliance with the Health Insurance Portability and Accountability Act ("HIPAA") Privacy and Security Rules and Breach Notification standard...http://www.cooley.com/showalert.aspx?Show=66038Wed, 18 Jan 2012 00:00:00 GMTBarbara Kosacz, partner and chair of Cooley's Life Sciences practice group, was interviewed about Reata Pharmaceutical's $400 million deal with Abbott.View the article here.http://www.cooley.com/showinthenews.aspx?Show=66013Tue, 13 Dec 2011 00:00:00 GMTThe Cooley team advising on the transaction was led by partners Kay Chandler, Jason Kent, special counsel Rama Padmanabhan and partner Fred Muto and included associates Jon Russo and Kayla Berkman, partners Mark Windfeld-Hansen, Howard Morse, Kathleen Goodhart, Natasha Leskovsek&...http://www.cooley.com/showpressrelease.aspx?Show=65791Wed, 23 Nov 2011 00:00:00 GMTPalo Alto, Calif. – November 1, 2011 – Cooley LLP has been named Biotechnology "Law Firm of the Year" in the newly released 2011-2012 U.S. News – Best Lawyers "Best Law Firms" Ranking.  Cooley consistently ranks #1 for representation of life sciences companies. In the past decade, Cooley has co...http://www.cooley.com/showpressrelease.aspx?Show=65716Tue, 01 Nov 2011 00:00:00 GMTSan Francisco, Calif. – October 21, 2011 – Parallel teams of Cooley litigators and business lawyers delivered a favorable outcome last week on behalf of longtime client Onyx Pharmaceuticals, Inc, which reached a settlement of a jury trial in a dispute with its partner, the international pharmaceutic...http://www.cooley.com/showpressrelease.aspx?Show=65687Fri, 21 Oct 2011 00:00:00 GMTBarclay Kamb, Partner in Cooley's Life Sciences practice group, was quoted in an article on the implications of the recent SIGA-PharmAthene ruling.  The Delaware Court of Chancery's ruling is a cautionary tale for business development professionals and the risks associated with failed merg...http://www.cooley.com/showinthenews.aspx?Show=65674Mon, 03 Oct 2011 00:00:00 GMTBy Daniel Wilson Cooley LLP announced Monday that it had added three life sciences intellectual property partners from Seed Intellectual Property Law Group PLLC to its Seattle office. The team includes Bill Christiansen, Carol Laherty and Emily Wagner. They will work on patent procurement and port...http://www.cooley.com/showinthenews.aspx?Show=65505Tue, 09 Aug 2011 00:00:00 GMTBill Christiansen, Emily Wagner and Carol Laherty joined Cooley as partners today from Seed IP.  All three are joining Cooley's Intellectual Property practice group and will be resident in the Seattle office. View the full article here.http://www.cooley.com/showinthenews.aspx?Show=65506Mon, 08 Aug 2011 00:00:00 GMT